IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV10I4A84

Novel indication for bioabsorbable scaffolds in metal allergy

Niket Patel*, MBBS, BSc, MRCP; Anthony Mechery, MBBS, MD, DM, MRCP; George Kassimis, MD, PhD; Adrian P. Banning, MBBS, MD, FRCP; Rajesh Kharbanda, MBChB, PhD, MRCP

A 74-year-old female with exertional breathlessness and a metal allergy underwent angiography following positive stress echocardiography. This demonstrated severe calcific disease of the left anterior descending artery (LAD) (Figure 1A). Percutaneous intervention (PCI) was offered after the failure of medical therapy.

Figure 1. A) Calcified mid-LAD lesion. B) Unsuccessful predilation (significant wasting). C) Post-rotablation lesion expansion. D) Result following two overlapping Abbott BVS.

Patch testing confirmed allergy to nickel and cobalt. Most stent platforms contain alloys that include nickel (Table 1), which may contribute to restenosis in this context.

Balloon predilation was unsuccessful (Figure 1B). Therefore, rotablation with a 1.5 mm burr (Boston Scientific, Natick, MA, USA) was performed. After further predilation (Figure 1C) and QCA, overlapping 3×28 mm and 3.5×28 mm ABSORB Revision 1.1 bioabsorbable scaffolds (BVS) (Abbott Vascular, Santa Clara, CA, USA) (Figure 1C) were implanted. Postdilation with a non-compliant 3.25 mm balloon was performed (Figure 1D). The patient was symptom free at six-month review.

Although nickel allergy is not a conventional contraindication to stenting, bioabsorbable scaffolds such as the poly-L-lactide Abbott BVS now provide an alternative interventional strategy to metallic stents in this situation. Additionally, this case exemplifies the use of this technology in complex lesions.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 10 Number 4
Aug 19, 2014
Volume 10 Number 4
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-18-00400 Sep 20, 2019
Bioresorbable magnesium scaffold in complex PCI in a nickel allergy patient: one-year follow-up – no disease, no scaffolds
Bayón J et al
free

10.4244/EIJV11I12A259 Mar 18, 2016
Oversized post-dilatation of current bioresorbable vascular scaffolds: kill or cure?
von Birgelen C and Basalus M
free

EXPERT REVIEW

10.4244/EIJ-D-17-00499 Aug 25, 2017
State of the art: the inception, advent and future of fully bioresorbable scaffolds
Katagiri Y et al
free

Dec 30, 2009
A.R.T.: concept of a bioresorbable stent without drug elution
Lafont A and Durand E
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-16-00981 Dec 20, 2017
Evidence of acute giant cell reaction post bioresorbable vascular scaffold implantation
Mulligan A et al
free

Image – Interventional flashlight

10.4244/EIJ-D-18-00501 Jul 19, 2019
“Bumpy” neointima: the fingerprint of bioabsorbable magnesium scaffold resorption
Alfonso F et al
free

Debate

10.4244/EIJ-E-23-00015 Jun 19, 2023
Bioresorbable coronary scaffolds are ready for a comeback: pros and cons
Stone GW et al
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved